Sanofi SA
PAR:SAN
Sanofi SA
Cash from Financing Activities
Sanofi SA
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sanofi SA
PAR:SAN
|
Cash from Financing Activities
-€8.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-8%
|
|
Ipsen SA
PAR:IPN
|
Cash from Financing Activities
-€458.4m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-20%
|
|
Vetoquinol SA
PAR:VETO
|
Cash from Financing Activities
-€18m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Virbac SA
PAR:VIRP
|
Cash from Financing Activities
-€2.7m
|
CAGR 3-Years
80%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Boiron SA
PAR:BOI
|
Cash from Financing Activities
-€21.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
24%
|
CAGR 10-Years
11%
|
|
Medincell SA
PAR:MEDCL
|
Cash from Financing Activities
€1.6m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
See Also
What is Sanofi SA's Cash from Financing Activities?
Cash from Financing Activities
-8.1B
EUR
Based on the financial report for Dec 31, 2023, Sanofi SA's Cash from Financing Activities amounts to -8.1B EUR.
What is Sanofi SA's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-8%
Over the last year, the Cash from Financing Activities growth was -38%. The average annual Cash from Financing Activities growth rates for Sanofi SA have been -7% over the past three years , and -8% over the past ten years .